js","9897","static/chunks/9897-96ec494a15704266.js","4005","static/chunks/4005-f97caa47699c0d92.js","9180","static/chunks/9180-141aeb8e4de0fb19.js","855","static/chunks/855-cf19c6c21b03f067.js","5208","static/chunks/5208-62bc554de8278993.js","1094","static/chunks/1094-e2bede973ee0fcba.js","261","static/chunks/261-62d59822d4693e14.js","105","static/chunks/105-0cf779e7b5058905.js","3204","static/chunks/3204-771fe8926763857e.js","1416","static/chunks/1416-2c3ea9586cfb2d8c.js","5657","static/chunks/5657-7d7ce34b53a75bbe.js","3864","static/chunks/3864-e65f5ab7d1e2b87f.js","6936","static/chunks/6936-95130c4492d838b4.js","8678","static/chunks/8678-a0502ad698b1d653.js","9781","static/chunks/9781-cfd3d6d9018cf1de.js","5181","static/chunks/5181-7cb9d448d4c5f6b5.js","1730","static/chunks/1730-e164aa8f11e16aba.js","7755","static/chunks/7755-a0da8883abfcfd81.js","7946","static/chunks/7946-aed52829e81f011b.js","8422","static/chunks/8422-2eeeb4781ba7854c.js","9077","static/chunks/9077-b99ded772bea5001.js","4586","static/chunks/4586-c19be489e417e49c.js","1324","static/chunks/1324-0939666a4c952298.js","7107","static/chunks/7107-4c801ae286d6095d.js","4755","static/chunks/4755-3c4b0c8adb59bcb9.js","5458","static/chunks/app/dashboard/episodes/%5Bid%5D/page-c181d169ce19ca2c.js"],"EpisodeRecommend"] 24:T621,

The boom in the creation of companies that were launched in the West based on assets sourced in Asia signals China’s galloping speed of innovation. On the latest BioCentury This Week podcast, BioCentury’s editors discuss the “NewCo Model,” who the players are, from CEOs and companies to investors; the areas of innovation the start-ups are tackling; and the evolution of the trend. (Read about the company that kicked off the trend, Arrivent, here.)
The editors also assess how personnel losses a

Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug

BioCentury This Week